From January 1, 2022 to March 31, 2022, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 648,844 shares, representing 2.17% for $226.91 million under the buyback announced on November 28, 2017.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
282 USD | +0.76% | +1.75% | -12.67% |
29/04 | RBC Capital Adjusts Price Target on Bio-Rad Laboratories to $420 From $474 | MT |
26/04 | Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.67% | 8.03B | |
-4.02% | 184B | |
-0.75% | 109B | |
-2.97% | 68.37B | |
+4.48% | 51.56B | |
+9.09% | 44.69B | |
+4.37% | 41.49B | |
+3.12% | 26.75B | |
+4.10% | 26.7B | |
+15.38% | 25.68B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on November 28, 2017.